OQS
TNYA icon

Occudo Quantitative Strategies’s Tenaya Therapeutics TNYA Stock Holding History

Occudo Quantitative Strategies’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,691
Closed -$53.6K – 1204
2022
Q4 		$53.6K Buy
26,691
+666
+3% +$1.63K 0.01% 881
2022
Q3 		$75K Buy
+26,025
New +$121K 0.01% 1061

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ROTUOC
Regents of the University of California Oakland, California $3.01B AUM 11.91% 1-Year Est. Return

Occudo Quantitative Strategies's TNYA Position: Q1 2023 in Review

Occudo Quantitative Strategies sold out of Tenaya Therapeutics (TNYA) in Q1 2023, closing a stake of 26,691 shares — an estimated $53.6K sold.

Occudo Quantitative Strategies first reported a position in TNYA in Q3 2022 and held it in 2 quarters. The position peaked at $75K in Q3 2022. 64 funds tracked by Wall St. Rank hold TNYA as of Q1 2023.

  • Occudo Quantitative Strategies reported no remaining Tenaya Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 26,691 Tenaya Therapeutics shares in Q1 2023, an estimated $53.6K.
  • Occudo Quantitative Strategies first reported a position in Tenaya Therapeutics in Q3 2022 and held it in 2 quarters.
  • Occudo Quantitative Strategies's Tenaya Therapeutics position peaked at $75K in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2023, filed 15 May 2023.